Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.2888
+0.0039 (1.37%)
At close: Jun 3, 2025, 4:00 PM
0.2900
+0.0012 (0.42%)
After-hours: Jun 3, 2025, 7:59 PM EDT

Adaptimmune Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
41.0591.14143.99108.03149.9556.88
Upgrade
Short-Term Investments
18.5160.472.9596.57219.63311.34
Upgrade
Cash & Short-Term Investments
59.56151.61146.94204.61369.58368.22
Upgrade
Cash Growth
-58.54%3.18%-28.18%-44.64%0.37%311.22%
Upgrade
Accounts Receivable
4.381.450.827.440.750.14
Upgrade
Other Receivables
16.4714.5346.130.6533.2620.95
Upgrade
Receivables
20.8515.9846.9238.0934.0121.09
Upgrade
Inventory
11.767.381.331.280.752.09
Upgrade
Prepaid Expenses
7.4810.039.959.479.046.31
Upgrade
Other Current Assets
3.353.172.411.932.080.44
Upgrade
Total Current Assets
103188.17207.55255.37415.46398.15
Upgrade
Property, Plant & Equipment
48.9451.2271.7171.5451.3746.66
Upgrade
Other Intangible Assets
3.813.880.330.4411.73
Upgrade
Other Long-Term Assets
2.332.73.031.571.724.6
Upgrade
Total Assets
158.07245.96282.62328.92469.55451.14
Upgrade
Accounts Payable
5.78.698.134.758.116.39
Upgrade
Accrued Expenses
22.2230.928.8529.0629.5827.03
Upgrade
Current Portion of Leases
4.634.715.382.732.322.77
Upgrade
Current Income Taxes Payable
--1.4---
Upgrade
Current Unearned Revenue
12.4412.328.9723.5222.22.83
Upgrade
Other Current Liabilities
6.097.930.054.440.330.05
Upgrade
Total Current Liabilities
51.0764.5372.7964.562.5439.07
Upgrade
Long-Term Debt
25.4150.24----
Upgrade
Long-Term Leases
18.6719.2619.8520.3523.1520.94
Upgrade
Long-Term Unearned Revenue
95.9895.82149.06160.89177.2249.26
Upgrade
Other Long-Term Liabilities
4.374.271.41.30.670.64
Upgrade
Total Liabilities
195.5234.11243.1247.04263.59109.92
Upgrade
Common Stock
2.12.091.871.41.341.33
Upgrade
Additional Paid-In Capital
1,1061,1061,065990.66959.61935.71
Upgrade
Retained Earnings
-1,142-1,094-1,023-909.3-743.85-585.76
Upgrade
Comprehensive Income & Other
-4.41-1.9-3.75-0.88-11.14-10.05
Upgrade
Shareholders' Equity
-37.4311.8539.5181.88205.96341.23
Upgrade
Total Liabilities & Equity
158.07245.96282.62328.92469.55451.14
Upgrade
Total Debt
48.7174.2125.2423.0825.4723.71
Upgrade
Net Cash (Debt)
10.8677.4121.7181.53344.11344.51
Upgrade
Net Cash Growth
-90.95%-36.41%-32.96%-47.25%-0.11%437.59%
Upgrade
Net Cash Per Share
0.040.310.611.132.212.42
Upgrade
Filing Date Shares Outstanding
265.05257.23246.83165.31156.73155.14
Upgrade
Total Common Shares Outstanding
257.85255.94227.17164.52156.26154.79
Upgrade
Working Capital
51.93123.64134.76190.87352.92359.08
Upgrade
Book Value Per Share
-0.150.050.170.501.322.20
Upgrade
Tangible Book Value
-41.247.9739.1881.44204.96339.5
Upgrade
Tangible Book Value Per Share
-0.160.030.170.491.312.19
Upgrade
Machinery
-39.9138.9734.9232.6530.52
Upgrade
Construction In Progress
-0.280.0528.735.4-
Upgrade
Leasehold Improvements
-43.0157.9428.4628.728.36
Upgrade
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q